Content about Treatment of bipolar disorder

September 28, 2011

A new report from the Department of Health and Human Services' Agency for Healthcare Research and Quality found little evidence to support the use of atypical antipsychotic drugs for uses other than those for which they have official approval.

ROCKVILLE, Md. — A new report from the Department of Health and Human Services' Agency for Healthcare Research and Quality found little evidence to support the use of atypical antipsychotic drugs for uses other than those for which they have official approval.

August 10, 2011

Omega-3 polyunsaturated fats, or PUFAs, found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research released Wednesday.

DENVER — Omega-3 polyunsaturated fats, or PUFAs, found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research released Wednesday.

"The consumption of nearly 1 g of omega-3s per day may improve the elasticity of the arteries, especially in individuals at high risk of heart disease," PUFA Newsletter editor Joyce Nettleton said. "Measurement of arterial stiffness is a powerful predictor of future heart events and the risk of dementia and death."

July 11, 2011

Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.

BRIDGEWATER, N.J. — Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.

July 7, 2011

Positioned as the first all-natural line made with certified organic hemp seed oil is the North American Hemp line of personal products. The collection includes bath, body and hair care products all made with certified organic hemp seed oil. According to the manufacturer, hemp has excellent healing and moisturizing properties, and hemp seed oil in hair care products provides rich omega-3, -6, and -9 essential fatty acids.

Positioned as the first all-natural line made with certified organic hemp seed oil is the North American Hemp line of personal products. The collection includes bath, body and hair care products all made with certified organic hemp seed oil. According to the manufacturer, hemp has excellent healing and moisturizing properties, and hemp seed oil in hair care products provides rich omega-3, -6, and -9 essential fatty acids. Hemp seed oil also benefits skin.

June 20, 2011

Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.

TITUSVILLE, N.J. — Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.

J&J subsidiary Ortho-McNeil-Janssen Pharmaceuticals announced the voluntary recall of one lot of Risperdal (risperidone) tablets in the 3-mg strength and a lot of authorized generic risperidone tablets in the 2-mg strength made by Patriot Pharmaceuticals, also a J&J subsidiary.

May 23, 2011

The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

PITTSBURGH — The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

Mylan said Monday that the FDA had approved its divalproex sodium capsules in the 125-mg strength. The drug is a generic version of Abbott’s Depakote Sprinkle capsules and is used to treat certain types of epileptic seizures.

Divalproex sodium capsules had sales of about $89 million during the 12-month period ended in March, according to IMS Health.

May 23, 2011

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


SUPPLIER NEWS — The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 20, 2011

The Council for Responsible Nutrition on Thursday issued a statement regarding the growing controversy surrounding Lazy Cakes — a brownie containing melatonin, an ingredient that helps establish more normal sleeping patterns — that has been cited in a New York Times article as having “flagrantly mimic[ked] the soothing effects of hash brownies.”

WASHINGTON — The Council for Responsible Nutrition on Thursday issued a statement regarding the growing controversy surrounding Lazy Cakes — a brownie containing melatonin, an ingredient that helps establish more normal sleeping patterns — that has been cited in a New York Times article as having “flagrantly mimic[ked] the soothing effects of hash brownies.”

Other published reports suggested the Arizona Department of Health issued a mandatory recall of Lazy Cakes following the report of an adverse event.

April 11, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

TITUSVILLE, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

J&J said Monday that the FDA had approved Invega (paliperidone) extended-release tablets for patients ages 12 to 17 years. The drug is marketed by J&J subsidiary Ortho-McNeil-Janssen Pharmaceuticals. The drug originally was approved in 2006 for treating schizophrenia in adults.

April 4, 2011

Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.

TORONTO — Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.

Intellipharmaceutics announced Monday that it had filed an application with the Food and Drug Administration for quetiapine fumarate extended-release tablets, a generic version of AstraZeneca’s Seroquel XR.

March 4, 2011

Pregnant mothers taking a common drug for treating epilepsy may be putting their babies at risk, according to a new report from the Food and Drug Administration.

SILVER SPRING, Md. — Pregnant mothers taking a common drug for treating epilepsy may be putting their babies at risk, according to a new report from the Food and Drug Administration.

The FDA said Friday that the drug topiramate could increase the risk for such birth defects as cleft palate and cleft lip when used by expectant mothers. Johnson & Johnson markets the drug under the name Topamax, and it is available in generic form.

February 17, 2011

The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

PRINCETON, N.J. — The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

The FDA approved Abilify (aripiprazole), made by Bristol-Myers Squibb and Otsuka Pharmaceutical, as an adjunct to lithium or valproate for maintenance treatment of bipolar I disorder.

January 25, 2011

Nordic Naturals on Tuesday introduced its new Daily Omega brand, a line of three omega-3 products.

WATSONVILLE, Calif. — Nordic Naturals on Tuesday introduced its new Daily Omega brand, a line of three omega-3 products.

"Consumers have a large variety of products to choose from when it comes to omega-3 fatty acids, and this can be quite confusing,” stated Corinna Bellizzi, retail division sales manager for Nordic. “Daily Omega makes this choice easy by offering three concentrated formulas — two for adults and one for children — where only one soft gel is required daily to support optimal health and wellness."

December 8, 2010

The American College of Neuropsychopharmacology on Wednesday presented a new analysis of the effects of omega-3 essential fatty acids as potential treatment options for depression.

MIAMI — The American College of Neuropsychopharmacology on Wednesday presented a new analysis of the effects of omega-3 essential fatty acids as potential treatment options for depression.

Two critical omega-3 essential fatty acids available from certain food or nutritional supplements but not manufactured by the body — eicosapentenoic acid and docosahexaenoic — play a role in optimal brain functioning and have antidepressant benefits that have not been fully recognized, the professional society stated during its annual meeting in Miami.

October 28, 2010

The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency...

SILVER SPRING, Md. The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

October 20, 2010

The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan...

PITTSBURGH The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan said Thursday.

 

The drug maker announced the approval of pramipexole dihydrochloride tablets in the 0.125-mg, 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths. The drug is a generic version of Boehringer Ingelheim’s Mirapex.

 

 

September 26, 2010

Supermarket chain Stater Bros. is marking National Breast Cancer Awareness Month in October by giving...

SAN BERNARDINO, Calif, Supermarket chain Stater Bros. is marking National Breast Cancer Awareness Month in October by giving away a drug used to treat the disease.

 

The chain announced Monday that it would provide 30-day supplies of the drug tamoxifen for free to patients with valid prescriptions at all of its 28 stores.

 

 

September 8, 2010

Merck's supplemental drug applications for its atypical antipsychotic received approval from the Food and Drug...

WHITEHOUSE STATION, N.J. Merck's supplemental drug applications for its atypical antipsychotic received approval from the Food and Drug Administration, the drug maker said.

Saphris now is indicated for the treatment of schizophrenia in adults, as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, and as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, Merck said.

August 10, 2010

The drug market for unipolar depression will get smaller over the next decade due to...

August 9, 2010

Drug maker Angelini Labopharm has launched a new treatment for depression....

August 8, 2010

Anglo-Swedish drug maker AstraZeneca has settled 17,500 product liability cases involving one of its drugs,...

June 10, 2010

Health insurer Blue Cross Blue Shield of Texas alleged that drug maker Pfizer marketed its...

May 13, 2010

Off-label use of atypical antipsychotics may increase the risk of developing diabetes among the elderly,...

March 22, 2010

Less than a month after winning approval for treating early stages of Parkinson’s disease, a...

March 17, 2010

A state judge in New Jersey has ruled in favor of AstraZeneca in the case...